Literature DB >> 16138494

The prevention of cardiovascular disease worldwide: whose task and WHO's task?

Philip Poole-Wilson1.   

Abstract

Cardiovascular disease is the commonest chronic illness in both developed and developing countries, causing the most deaths and the greatest impact on morbidity. The superiority of disease prevention over treatment was appreciated at least 5,000 years ago in China. The link between the existence of disease in society and the political and social circumstances of a country was emphasised by Virchow in the nineteenth century. The scientific basis and methods for prevention of cardiovascular disease are known. What are lacking are the will and the means to implement change. The well-intentioned often have a dominant sense of entitlement in the pursuit of the common goal of disease prevention. There is a failure of many organisations to acknowledge the importance of other groups within society in achieving the common goal. Doctors, particularly cardiovascular physicians and cardiologists, must play a much greater role in linking with the public, other health workers, epidemiologists, media, industry, academia and politicians. Too many vested interests obstruct progress in the prevention of cardiovascular disease.

Entities:  

Mesh:

Year:  2005        PMID: 16138494      PMCID: PMC4954212          DOI: 10.7861/clinmedicine.5-4-379

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  8 in total

1.  Cardiovascular disease risk factors and diabetes in Asian Indians residing in Michigan.

Authors:  Tsu-Yin Wu; Jing Wang; Scott Chung
Journal:  J Community Health       Date:  2012-04

2.  Targeted In Situ Gene Correction of Dysfunctional APOE Alleles to Produce Atheroprotective Plasma ApoE3 Protein.

Authors:  Ioannis Papaioannou; J Paul Simons; James S Owen
Journal:  Cardiol Res Pract       Date:  2012-05-07       Impact factor: 1.866

3.  Translating policy into practice: a case study in the secondary prevention of coronary heart disease.

Authors:  Lindsay Prior; Joanne Wilson; Michael Donnelly; Andrew W Murphy; Susan M Smith; Mary Byrne; Molly Byrne; Margaret E Cupples
Journal:  Health Expect       Date:  2011-12-12       Impact factor: 3.377

4.  Insights into the development and treatment of cardiovascular disease: a role for animal models.

Authors:  Cecil S Thompson
Journal:  Open Cardiovasc Med J       Date:  2010-11-26

5.  The role of miR‑370 in fibrosis after myocardial infarction.

Authors:  Hui Yuan; Jie Gao
Journal:  Mol Med Rep       Date:  2017-03-27       Impact factor: 2.952

6.  Primary Causes of Hospitalizations and Procedures, Predictors of In-hospital Mortality, and Trends in Cardiovascular and Cerebrovascular Events Among Recreational Marijuana Users: A Five-year Nationwide Inpatient Assessment in the United States.

Authors:  Rupak Desai; Sofia Shamim; Krupa Patel; Ashish Sadolikar; Vikram Preet Kaur; Siddhi Bhivandkar; Smit Patel; Sejal Savani; Zeeshan Mansuri; Zabeen Mahuwala
Journal:  Cureus       Date:  2018-08-23

7.  Cardiovascular risk assessment in low-resource settings: a consensus document of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk in Low Resource Settings.

Authors:  Pietro A Modesti; Piergiuseppe Agostoni; Charles Agyemang; Sanjay Basu; Athanase Benetos; Francesco P Cappuccio; Antonio Ceriello; Stefano Del Prato; Robert Kalyesubula; Eoin O'Brien; Michael O Kilama; Stefano Perlini; Eugenio Picano; Gianpaolo Reboldi; Giuseppe Remuzzi; David Stuckler; Marc Twagirumukiza; Luc M Van Bortel; Ghassan Watfa; Dong Zhao; Gianfranco Parati
Journal:  J Hypertens       Date:  2014-05       Impact factor: 4.844

8.  Upregulation of microRNA-206 induces apoptosis of vascular smooth muscle cells and decreases risk of atherosclerosis through modulating FOXP1.

Authors:  Tao Xing; Lixin Du; Xianbo Zhuang; Liyong Zhang; Jiheng Hao; Jiyue Wang
Journal:  Exp Ther Med       Date:  2017-08-30       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.